Skip to main content
TipRanks
Go Ultimate75% OFF

TransCode Therapeutics (RNAZ) Q2 2022 Earnings Report

447 Followers

RNAZ Q2 2022 EPS Results

Actual EPS
-$266,112.00
Consensus EPS
-$266,112.00
Beat/Miss
Met expectations
One Year Ago EPS
$158,721.02

RNAZ Q2 2022 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2022
Date
08/15/2022
Time
After Close
Conference Call
Monday, August 15, 2022

Q2 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

RNAZ Earnings History

RNAZ earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 28, 20252024 (Q4)-105.93-8.50-805.298.94% (+796.70)
Nov 11, 20242024 (Q3)-16.17-5.28-2217.699.76% (+2212.32)
Aug 12, 20242024 (Q2)-0.58-0.74-131.699.44% (+130.86)
May 13, 20242024 (Q1)―--0.33―
Apr 03, 20242023 (Q4)-646.80-600.60-12196.895.08% (+11596.20)
Nov 14, 20232023 (Q3)-55440.00-62092.80-24393674.55% (+181843.20)
Aug 14, 20232023 (Q2)-121598.40-121598.40-26611254.31% (+144513.60)
May 15, 20232023 (Q1)―--0.27―
Mar 31, 20232022 (Q4)―-12196.80-19958493.89% (+187387.20)
Nov 14, 20222022 (Q3)-243936.00-243936.00-147840-65.00% (-96096.00)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed